Strides Pharma Science arm gets USFDA nod for tension headache tablets
Strides Pharma Global Pte Ltd, Singapore, has received approval for Butalbital, Acetaminophen, and Caffeine tablets USP in the strengths of 50 mg/325 mg/40 mg from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Acetaminophen | Biotechnology | Butalbital | Caffeine | Food and Drug Administration (FDA) | Headache | Lortab | Migraine | Pharmaceuticals | Science | Singapore Health | USA Health